Literature DB >> 31513791

An Empirical Mediation Analysis of Mechanisms Underlying HIV-1-Associated Neurocognitive Disorders.

Kristen A McLaurin1, Charles F Mactutus2, Rosemarie M Booze1, Amanda J Fairchild3.   

Abstract

HIV-1-associated neurocognitive disorders (HAND), characterized by alterations in the core components of cognitive function and age-related disease progression, persist in the post-cART era. However, the neurobehavioral mechanisms that mediate alterations in the core components of cognitive function and the progression of neurocognitive impairments have yet to be systematically evaluated. To address this knowledge gap, statistical mediation analysis was assessed, providing a critical opportunity to empirically evaluate putative neurobehavioral mechanisms underlying HAND. Neurocognitive assessments, conducted in HIV-1 transgenic (Tg) and control animals across the functional lifespan (i.e., Postnatal Day (PD) 30 to PD 600), tapped multiple cognitive domains including preattentive processes, learning, sustained attention, and long-term episodic memory. Three longitudinal mediation models were utilized to assess whether deficits in preattentive processes mediate alterations in learning, sustained attention and/or long-term episodic memory over time. Preattentive processes partially mediated the relationship between genotype and learning, genotype and sustained attention, and genotype and long-term episodic memory across the functional lifespan, explaining between 44% and 58% of the HIV-1 transgene effect. Understanding the neurobehavioral mechanisms mediating alterations in HAND may provide key targets for the development of a diagnostic biomarker, novel therapeutics, and cure/restoration strategies.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Episodic memory; HIV-1 associated neurocognitive disorders; Mediation analysis; Preattentive processes; Sustained attention; Temporal processing

Year:  2019        PMID: 31513791      PMCID: PMC7092796          DOI: 10.1016/j.brainres.2019.146436

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  95 in total

1.  Neurodegenerative diseases.

Authors:  Marie-Thérèse Heemels
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

2.  Elevated Depressive Symptoms Are a Stronger Predictor of Executive Dysfunction in HIV-Infected Women Than in Men.

Authors:  Leah H Rubin; Gayle Springer; Eileen M Martin; Eric C Seaberg; Ned C Sacktor; Andrew Levine; Victor G Valcour; Mary A Young; James T Becker; Pauline M Maki
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

Review 3.  Some statistical and experimental considerations in the use of the analysis-of-variance procedure.

Authors:  V H Denenberg
Journal:  Am J Physiol       Date:  1984-04

4.  Using intracranial electrical stimulation to study the timing of prepulse inhibition of the startle reflex.

Authors:  L Li; J S Yeomans
Journal:  Brain Res Brain Res Protoc       Date:  2000-02

5.  Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance.

Authors:  Adarsh M Kumar; Raymond L Ownby; Drenna Waldrop-Valverde; Benny Fernandez; Mahendra Kumar
Journal:  J Neurovirol       Date:  2010-12-14       Impact factor: 2.643

6.  HIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens.

Authors:  Robert F Roscoe; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neuroimmune Pharmacol       Date:  2014-07-19       Impact factor: 4.147

7.  Time and time again: temporal processing demands implicate perceptual and gating deficits in the HIV-1 transgenic rat.

Authors:  Landhing M Moran; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-21       Impact factor: 4.147

Review 8.  Translating cognition from animals to humans.

Authors:  J F Keeler; T W Robbins
Journal:  Biochem Pharmacol       Date:  2011-01-08       Impact factor: 5.858

9.  Disruption of Timing: NeuroHIV Progression in the Post-cART Era.

Authors:  Kristen A McLaurin; Hailong Li; Rosemarie M Booze; Charles F Mactutus
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

Review 10.  Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature.

Authors:  Amy R Zipursky; David Gogolishvili; Sergio Rueda; Jason Brunetta; Adriana Carvalhal; Jennifer A McCombe; M John Gill; Anita Rachlis; Ron Rosenes; Gordon Arbess; Thomas Marcotte; Sean B Rourke
Journal:  AIDS       Date:  2013-09-24       Impact factor: 4.177

View more
  5 in total

1.  S-EQUOL: a neuroprotective therapeutic for chronic neurocognitive impairments in pediatric HIV.

Authors:  Kristen A McLaurin; Hailong Li; Anna K Cook; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2020-09-01       Impact factor: 2.643

2.  Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage.

Authors:  Adam R Denton; Charles F Mactutus; Almeera U Lateef; Steven B Harrod; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2021-05-18       Impact factor: 3.739

3.  Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders.

Authors:  Kristen A McLaurin; Landhing M Moran; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-19       Impact factor: 4.147

4.  Intraneuronal β-Amyloid Accumulation: Aging HIV-1 Human and HIV-1 Transgenic Rat Brain.

Authors:  Hailong Li; Kristen A McLaurin; Charles F Mactutus; Benjamin Likins; Wenfei Huang; Sulie L Chang; Rosemarie M Booze
Journal:  Viruses       Date:  2022-06-10       Impact factor: 5.818

5.  Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders.

Authors:  Hailong Li; Kristen A McLaurin; Jessica M Illenberger; Charles F Mactutus; Rosemarie M Booze
Journal:  Viruses       Date:  2021-05-17       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.